학술논문
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
Document Type
Letter
Author
Source
In: Annals of Hematology . (Annals of Hematology, April 2022, 101(4):929-931)
Subject
Language
English
ISSN
14320584
09395555
09395555